Get the Stockscreener App
7.27
126.27%
4.11
Polyrizon Ltd stock is traded at $7.27, with a volume of 144.49M.
It is up +126.27% in the last 24 hours and up +16.83% over the past month.
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.
See More
Previous Close:
$3.16
Open:
$6.97
24h Volume:
144.49M
Relative Volume:
64.57
Market Cap:
$7.57M
Revenue:
-
Net Income/Loss:
$-1.13M
P/E Ratio:
-0.1272
EPS:
-57.1626
Net Cash Flow:
$-2.63M
1W Performance:
+104.44%
1M Performance:
+16.83%
6M Performance:
+54.96%
1Y Performance:
-99.61%
1-Day Range:
$5.8501
$8.36
1-Week Range:
$2.88
$8.36
52-Week Range:
$2.88
$7,200.00
Polyrizon Ltd Stock (PLRZ) Company Profile
Compare PLRZ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PLRZ
Polyrizon Ltd
|
7.2656 | 3.29M | 0 | -1.13M | -2.63M | -57.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.80 | 107.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.75 | 78.84B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
466.63 | 60.05B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.64 | 55.10B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
206.70 | 45.09B | 447.02M | -1.18B | -906.14M | -6.1812 |
Polyrizon Ltd Stock (PLRZ) Latest News
Polyrizon Ltd.: Rapid Stock Movement – What’s Next? - StocksToTrade
Polyrizon (PLRZ) Stock: Nasal Spray Breakthrough Triggers Massive 108% Rally - parameter.io
Why Did Polyrizon Stock Soar Pre-Market Today? - Stocktwits
Polyrizon completes manufacturing upscaling for nasal spray technology By Investing.com - Investing.com India
Polyrizon completes manufacturing upscaling for nasal spray technology - Investing.com
Polyrizon completes manufacturing upscaling milestone for nasal spray platform - TipRanks
Polyrizon Achieves Key Manufacturing Milestone for Nasal Spray Platform - TipRanks
Polyrizon stock soars after successful manufacturing upscaling milestone By Investing.com - Investing.com UK
Polyrizon stock soars after successful manufacturing upscaling milestone - Investing.com
Polyrizon Announces Successful Completion of Key Manufacturing Upscaling Milestone for Its Nasal Spray Platform - MarketScreener
Polyrizon (Nasdaq: PLRZ) scales up PL-14 nasal spray production for 2026 trial - Stock Titan
Polyrizon Ltd. (PLRZ) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Polyrizon Ltd Stock Analysis and ForecastEarnings Season Recap & High Profit Market Growth - earlytimes.in
Polyrizon Ltd. Announces Reverse Share Split Effective November 28, 2025 - MSN
Polyrizon Ltd trading halted, news pending - MSN
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Risk Analysis: What risks investors should watch in Polyrizon Ltd. stockPortfolio Performance Summary & Low Risk High Reward Ideas - BỘ NỘI VỤ
Polyrizon Ltd. (PLRZ) -8.2% in Intraday Trading: Shares Decline Amid Routine Trading - Stocks Telegraph
[6-K] Polyrizon Ltd. Current Report (Foreign Issuer) | PLRZ SEC FilingForm 6-K - Stock Titan
Should I hold or sell Polyrizon Ltd. stock in 2025Quarterly Trade Report & Weekly Momentum Picks - newser.com
Is Polyrizon Ltd. stock a top momentum playPortfolio Profit Report & Reliable Price Breakout Alerts - newser.com
Will Polyrizon Ltd. stock recover faster than marketLayoff News & Smart Investment Allocation Insights - newser.com
How supply chain issues affect Polyrizon Ltd. stock2025 Volatility Report & Safe Capital Growth Stock Tips - newser.com
What MACD signals say about Polyrizon Ltd.Gap Down & High Conviction Buy Zone Picks - newser.com
Can trapped investors hope for a rebound in Polyrizon Ltd.2025 Volume Leaders & Technical Analysis for Trade Confirmation - newser.com
What Fibonacci levels say about Polyrizon Ltd. reboundStock Surge & Weekly Sector Rotation Insights - newser.com
Polyrizon announces in-vitro results for PL-16 Viral Blocker - MSN
Polyrizon Announces Breakthrough in Viral Blocking Nasal Gel - MSN
How to integrate Polyrizon Ltd. into portfolio analysis toolsJuly 2025 Outlook & Long-Term Safe Investment Ideas - newser.com
Can Polyrizon Ltd. stock hit analyst price targets2025 Key Highlights & Weekly High Return Stock Opportunities - newser.com
News impact scoring models applied to Polyrizon Ltd.July 2025 Momentum & AI Powered Market Trend Analysis - newser.com
What indicators show strength in Polyrizon Ltd.2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
Is Polyrizon Ltd. a candidate for recovery play2025 Breakouts & Breakdowns & Weekly Chart Analysis and Trade Guides - newser.com
Polyrizon Ltd Stock (PLRZ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):